Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist

Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Swetalina, Madke, Bhushan, Neema, Shekhar, Kabra, Poonam, Singh, Adarsh Lata, Yadav, Sangita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751712/
https://www.ncbi.nlm.nih.gov/pubmed/35068505
http://dx.doi.org/10.4103/ijd.IJD_649_16
_version_ 1784631735327129600
author Pradhan, Swetalina
Madke, Bhushan
Neema, Shekhar
Kabra, Poonam
Singh, Adarsh Lata
Yadav, Sangita
author_facet Pradhan, Swetalina
Madke, Bhushan
Neema, Shekhar
Kabra, Poonam
Singh, Adarsh Lata
Yadav, Sangita
author_sort Pradhan, Swetalina
collection PubMed
description Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI and anti-TNF-α agents and provides working guidelines for screening of LTBI and its management before prescribing anti-TNF-α therapy in patients with psoriasis.
format Online
Article
Text
id pubmed-8751712
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87517122022-01-21 Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist Pradhan, Swetalina Madke, Bhushan Neema, Shekhar Kabra, Poonam Singh, Adarsh Lata Yadav, Sangita Indian J Dermatol Review Article Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI and anti-TNF-α agents and provides working guidelines for screening of LTBI and its management before prescribing anti-TNF-α therapy in patients with psoriasis. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8751712/ /pubmed/35068505 http://dx.doi.org/10.4103/ijd.IJD_649_16 Text en Copyright: © 2021 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Pradhan, Swetalina
Madke, Bhushan
Neema, Shekhar
Kabra, Poonam
Singh, Adarsh Lata
Yadav, Sangita
Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist
title Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist
title_full Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist
title_fullStr Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist
title_full_unstemmed Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist
title_short Screening of Latent Tuberculous Infection (LTBI) before Starting Anti-Tumor Necrosis Factor Therapy in Patients with Psoriasis: A Primer for Clinical Dermatologist
title_sort screening of latent tuberculous infection (ltbi) before starting anti-tumor necrosis factor therapy in patients with psoriasis: a primer for clinical dermatologist
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751712/
https://www.ncbi.nlm.nih.gov/pubmed/35068505
http://dx.doi.org/10.4103/ijd.IJD_649_16
work_keys_str_mv AT pradhanswetalina screeningoflatenttuberculousinfectionltbibeforestartingantitumornecrosisfactortherapyinpatientswithpsoriasisaprimerforclinicaldermatologist
AT madkebhushan screeningoflatenttuberculousinfectionltbibeforestartingantitumornecrosisfactortherapyinpatientswithpsoriasisaprimerforclinicaldermatologist
AT neemashekhar screeningoflatenttuberculousinfectionltbibeforestartingantitumornecrosisfactortherapyinpatientswithpsoriasisaprimerforclinicaldermatologist
AT kabrapoonam screeningoflatenttuberculousinfectionltbibeforestartingantitumornecrosisfactortherapyinpatientswithpsoriasisaprimerforclinicaldermatologist
AT singhadarshlata screeningoflatenttuberculousinfectionltbibeforestartingantitumornecrosisfactortherapyinpatientswithpsoriasisaprimerforclinicaldermatologist
AT yadavsangita screeningoflatenttuberculousinfectionltbibeforestartingantitumornecrosisfactortherapyinpatientswithpsoriasisaprimerforclinicaldermatologist

Ejemplares similares